Melaleuca citrina

Classification

Distribution

Identification

Biological Activities

Melaleuca citrina, also known as Callistemon citrinus, demonstrates a wide range of significant therapeutic properties through its bioactive constituents. Research indicates that the plant possesses potent anticancer activity, specifically through the compound 1,8-Cineole which induces apoptosis in skin carcinoma cells. Furthermore, its extracts and isolated compounds like tormentic acid exhibit strong antimicrobial and antifungal activities against pathogens such as Candida albicans. The plant's leaves and flowers also serve as rich sources of phenolic and flavonoid compounds, contributing to a high antioxidant potential. Collectively, these findings highlight the diverse medicinal value of the species for potential pharmaceutical and nutraceutical applications.

Compounds

Melaleuca citrina, also known as Callistemon citrinus, is a medicinal plant characterized by a diverse array of bioactive chemical constituents. The aerial part essential oil is primarily composed of eucalyptol, which offers significant pharmacological potential for the flavor and fragrance industries. Detailed phytochemical analyses further reveal that the plant contains various polyphenols, including the antioxidant marker quercetin. Additionally, the species is a source of gallic acid, which is particularly observed in the flower extracts. Research also highlights the presence of tormentic acid, a compound found to possess notable antimicrobial and antifungal properties.

Conditions

Melaleuca citrina (also known as Callistemon citrinus) possesses significant antioxidant potential as demonstrated through various chemical assays. The essential oil of this plant exhibits antimicrobial activity against the bacterium B. cereus. Furthermore, the plant demonstrates effective antifungal properties against the pathogen Candida albicans. Research also indicates that its extracts are capable of inhibiting the growth of Candida tropicalis. These diverse biological activities highlight the plant's potential for pharmaceutical and nutraceutical applications.

Preparations

Melaleuca citrina extracts, also referred to as Callistemon citrinus, include a DCM: methanol extract that effectively inhibits the growth of Candida albicans. The plant is also prepared as an ethanol: water extract to study its impact on fungal pathogens. Furthermore, Melaleuca citrina is prepared as an aqueous extract, specifically seen in the seed extracts of related species like Callistemon lanceolatus which show broad antimicrobial potential. Research also involves Melaleuca citrina being prepared as aqueous fractions to identify bioactive compounds with relaxant properties. Finally, the plant is processed into various forms, including a crude methanol extract that is subsequently divided into different aqueous fractions for detailed phytochemical analysis.

Parts used

Melaleuca citrina is a medicinal plant of significant importance that contains various bioactive components distributed throughout its different structures. Scientific research has specifically identified the leaf as a rich source of polyphenols, flavonoids, and antioxidants. Additionally, the flowers of the plant serve as a vital repository for distinct phytochemicals like gallic acid. The seeds also play a crucial role, as their extracts demonstrate broad-spectrum antimicrobial potential against various pathogens. Together, these different parts highlight the complex biological value found within the entire plant.